SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001408617-07-000032
Filing Date
2007-11-16
Accepted
2007-11-16 09:45:23
Documents
1
Period of Report
2007-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2972
  Complete submission text file 0001408617-07-000032.txt   4818
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address MORRIS CORPORATE CENTER I 300 INTERPACE PARKWAY, BLDG B, 4TH FLOOR PARSIPPANY NJ 07054
Business Address 973-658-8600
Rackear Andrew D (Reporting) CIK: 0001408617 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23272 | Film No.: 071251602